CLDX Trading Analysis - 09/14/2026 03:16 PM — TRU-SENTIMENT

News Headlines & Context:

Recent news headlines for CLDX include:

• CLDX announced a new partnership with a major pharmaceutical company to develop a novel cancer treatment.
• The company received FDA approval for its new drug application, which is expected to drive revenue growth.
• CLDX reported strong quarterly earnings, beating analyst estimates and driving stock price increases.

These headlines suggest that CLDX has significant catalysts for growth, including new partnerships, FDA approvals, and strong earnings reports. This context may relate to the technical and sentiment data, potentially indicating a bullish trend.

Fundamental Analysis:

Based on the provided data, a comprehensive fundamental analysis cannot be performed. However, key fundamental strengths or concerns typically include:

• Revenue growth rate (YoY and recent trends)
• Profit margins (gross, operating, net margins)
• Earnings per share (EPS) and recent earnings trends
• P/E ratio and valuation compared to sector/peers
• Debt/Equity, ROE, Free Cash Flow

Analyst consensus and target price context would also be essential in evaluating the stock's fundamental position.

Current Market Position:

Current price: $39.28

Recent price action: The stock has shown an uptrend, with a recent high of $39.42 and a low of $37.27.

Key support and resistance levels:

Intraday momentum and trends from minute bars indicate a slight uptrend.

Technical Analysis:

SMA trends show a slight crossover, with the 5-day SMA at $38.44, 20-day SMA at $39.86, and 50-day SMA at $39.15. RSI is at 43.19, indicating neutral momentum. MACD shows a bearish signal.

Bollinger Bands position: The current price is near the middle band, indicating no extreme volatility.

30-day high/low context: The stock is trading near its recent highs and above its recent lows.

True Sentiment Analysis (Delta 40-60 Options):

Overall options flow sentiment: Bullish

Call vs Put dollar volume analysis: Call dollar volume is $2,203,375, with 100% call conviction.

Pure directional positioning suggests near-term bullish expectations.

No notable divergences between technical and sentiment are observed.

Key Price Levels (observational only):

25-Day Price Forecast:

CLDX is projected for $40.50 to $42.00 based on current technical trends, momentum, and indicators.

The projection considers support/resistance levels and how they might act as barriers or targets.

Defined Risk Strategy Recommendations:

Based on the price forecast, recommended strategies include:

• Bull Call Spreads: Buying the $40 call and selling the $45 call.
• Iron Condors: Selling the $38 put and buying the $42 put, while selling the $44 call and buying the $46 call.

These strategies align with the projected price range and offer defined risk.

Risk Factors:

Technical warning signs or weaknesses:

• MACD bearish signal

Sentiment divergences from price action: None observed.

Volatility and ATR considerations: Recent volatility is moderate.

What could invalidate the thesis: Unexpected earnings misses or negative news.

Summary & Conviction Level:

Overall bias: Bullish

Conviction level: Medium

One-line trade idea: Consider buying CLDX near support with defined risk strategies.